Transaction details
According to a Form 4 filing with the U.S. Securities and Exchange Commission, Serero Liron Netanela, an officer of Kaltura Inc. (NASDAQ: KLTR), purchased 5,000 shares of the company’s common stock on March 23, 2026. The transaction was executed at $1.28 per share for a total cost of $6,400. After the trade, Serero Liron Netanela directly holds 686,789 shares of Kaltura.
Market context
The purchase occurred while Kaltura shares were trading near $1.25, with the stock down approximately 26% over the preceding six months. The company’s recent fourth-quarter 2025 financial disclosure showed results that exceeded expectations, a development that has attracted investor and analyst attention.
Recent company performance
Kaltura reported fourth-quarter 2025 earnings per share of $0.03, compared with an expected $0.0006, which the filing characterizes as a 4,900% surprise relative to the consensus estimate. Revenue for the quarter totaled $45.5 million, slightly above the forecast of $45.32 million. These figures have been highlighted as strong financial performance for the period.
Analyst expectations
Market data cited in the filing indicate that analysts anticipate Kaltura will return to profitability this year, with forecasted earnings of $0.03 per share. Analysts covering the company have set price targets in a $3 to $4 range, implying substantial potential upside relative to the prevailing share price at the time of the insider purchase.
Prior insider activity and equity awards
On January 19, 2026, Serero Liron Netanela acquired 105,263 shares of common stock via restricted stock units. Those RSUs are scheduled to vest quarterly over a four-year period beginning April 1, 2026.
Market reaction and note
While the company’s stock experienced movements following the earnings release, the emphasis in public disclosures has been on the magnitude of the earnings beat and the modest revenue upside. The insider purchase is a relatively small open-market trade in dollar terms but follows a quarter that produced notable upside versus expectations.
This article presents the transaction and reported results without commentary beyond the facts disclosed in regulatory filings and company-reported figures.